Treatment outcomes of fixed-dose combination versus separate tablet regimens in pulmonary tuberculosis patients with or without diabetes in Qatar
Background: Tuberculosis is considered the second most common cause of death due to infectious agent. The currently preferred regimen for treatment of pulmonary tuberculosis (PTB) is isoniazid, rifampin, pyrazinamide, and ethambutol, which has been used either as separate tablets (ST) or as fixed-do...
Saved in:
| Main Author: | |
|---|---|
| Other Authors: | , , , |
| Format: | article |
| Published: |
2017
|
| Online Access: | http://hdl.handle.net/10725/6783 http://dx.doi.org/10.1186/s12879-017-2231-1 http://libraries.lau.edu.lb/research/laur/terms-of-use/articles.php https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-017-2231-1 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|